Fredun Pharmaceuticals Ltd

NSE: FREDUN · BSE: 539730 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹1,360.90
Market cap: ₹1,944 Cr
Revenue (annual): ₹635.5 Cr
Net profit (annual): ₹32.62 Cr
P/E (TTM): 44.4×Sector 50.4×
Promoter holding: 44.57%+0.40% QoQ
FII holding: 1.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Acquisition 2 Product Launch 1 Financial Results 1 Earnings Call 1 Capital Structure Change 1 Business Update 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

17 Aug 2026 16:20 IST BSE

Earnings Call

Fredun Pharmaceuticals Investor Presentation: Key Takeaways

Fredun Pharmaceuticals delivered explosive Q1 FY27 growth with standalone income rising 90.44% YoY to INR 228.25 cr and PAT up 94.63% to INR 13.17 cr.

Call: Guides 26% growth

Open call summary → Read the filing ↗